Page 28 - IDF Journal 2023
P. 28

IDF – Study Weekend IDF News – Spring 2023
REFERENCES
1. Wilens TE, Spencer TJ. Understanding attention-deficit/hyperactivity disorder from childhood to adulthood. Postgrad Med. 2010 Sep;122(5):97-109. doi: 10.3810/pgm.2010.09.2206. PMID: 20861593; PMCID: PMC3724232.
2. Sibley MH, Swanson JM, Arnold LE, Hechtman LT, Owens EB, Stehli A, Abikoff H, Hinshaw SP, Molina BSG, Mitchell JT, Jensen PS, Howard AL, Lakes KD, Pelham WE; MTA Cooperative Group. Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity. J Child Psychol Psychiatry. 2017 Jun;58(6):655-662. doi: 10.1111/jcpp.12620. Epub 2016 Sep 19. PMID: 27642116; PMCID: PMC5809153.
3. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA.
The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007 Jun;164(6):942-8. doi: 10.1176/ajp.2007.164.6.942. PMID: 17541055.
4. Kazda L, Bell K, Thomas R, McGeechan K, Sims R, Barratt A. Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review. JAMA Netw Open. 2021;4(4):e215335. doi:10.1001/jamanetworkopen.2021.5335
5. Ginsberg Y, Quintero J, Anand E, Casillas M, Upadhyaya HP. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. Prim Care Companion CNS Disord. 2014;16(3):PCC.13r01600. doi: 10.4088/PCC.13r01600. Epub 2014 Jun 12. PMID: 25317367; PMCID: PMC4195639.
6. Hamed AM, Kauer AJ, Stevens HE. Why the Diagnosis of Attention Deficit Hyperactivity Disorder Matters. Front Psychiatry. 2015 Nov 26;6:168. doi: 10.3389/fpsyt.2015.00168. PMID: 26635643; PMCID: PMC4659921.
7. Starck M, Grünwald J, Schlarb AA. Occurrence of ADHD in parents of ADHD children in a clinical sample. Neuropsychiatr Dis Treat. 2016 Mar 3;12:581-8. doi: 10.2147/NDT.S100238. PMID: 27042071; PMCID: PMC4780663.
8. Philip Asherson, ADHD across the lifespan, Medicine, Volume 48, Issue 11, 2020, Pages 737-741, ISSN 1357-3039, https://doi.org/10.1016/j. mpmed.2020.08.013.
9. https://www.adhdfoundation.org.uk/wp-content/uploads/2022/06/ Takeda_ADHD-in-the-CJS-Roundtable-Report_Final.pdf
10.Faraone SV, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove MA, Newcorn JH, Gignac M, Al Saud NM, Manor I, Rohde LA, Yang L, Cortese S, Almagor D, Stein MA, Albatti TH, Aljoudi HF, Alqahtani MMJ, Asherson P, Atwoli L, Bölte S, Buitelaar JK, Crunelle CL, Daley D, Dalsgaard S, Döpfner M, Espinet S, Fitzgerald M, Franke B, Gerlach M, Haavik J, Hartman CA, Hartung CM, Hinshaw SP, Hoekstra PJ, Hollis C, Kollins SH, Sandra Kooij JJ, Kuntsi J, Larsson H, Li T, Liu J, Merzon E, Mattingly G, Mattos P, McCarthy S, Mikami AY, Molina BSG, Nigg JT, Purper-Ouakil D, Omigbodun OO, Polanczyk GV, Pollak Y, Poulton AS, Rajkumar RP, Reding A, Reif A, Rubia K, Rucklidge J, Romanos M, Ramos-Quiroga JA, Schellekens A, Scheres A, Schoeman R, Schweitzer JB, Shah H, Solanto MV, Sonuga-Barke E, Soutullo C, Steinhausen HC, Swanson JM, Thapar A, Tripp G, van de Glind G, van den Brink W, Van der Oord S, Venter A, Vitiello B, Walitza S, Wang Y. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021 Sep;128:789-818. doi: 10.1016/j.neubiorev.2021.01.022. Epub 2021 Feb 4. PMID: 33549739; PMCID: PMC8328933.
11.Csecs JLL, Iodice V, Rae CL, Brooke A, Simmons R, Quadt L, Savage GK, Dowell NG, Prowse F, Themelis K, Mathias CJ, Critchley HD, Eccles JA. Joint Hypermobility Links Neurodivergence to Dysautonomia and Pain. Front Psychiatry. 2022 Feb 2;12:786916. doi: 10.3389/ fpsyt.2021.786916. PMID: 35185636; PMCID: PMC8847158
12.Hansen, T.F., Hoeffding, L.K., Kogelman, L. et al. Comorbidity of migraine with ADHD in adults. BMC Neurol 18, 147 (2018). https://doi. org/10.1186/s12883-018-1149-6
13.Ming X, Chen N, Ray C, Brewer G, Kornitzer J, Steer RA. A Gut Feeling: A Hypothesis of the Role of the Microbiome in Attention- Deficit/Hyperactivity Disorders. Child Neurology Open. 2018;5. doi:10.1177/2329048X18786799
14.DeCarlo DK, Swanson M, McGwin G, Visscher K, Owsley C. ADHD and Vision Problems in the National Survey of Children’s Health. Optom Vis Sci. 2016 May;93(5):459-65. doi: 10.1097/OPX.0000000000000823. PMID: 26855242; PMCID: PMC4840060.
15.Esteller-Cucala P, Maceda I, Børglum AD, Demontis D, Faraone SV, Cormand B, Lao O. Genomic analysis of the natural history of attention- deficit/hyperactivity disorder using Neanderthal and ancient Homo sapiens samples. Sci Rep. 2020 May 25;10(1):8622. doi: 10.1038/ s41598-020-65322-4. PMID: 32451437; PMCID: PMC7248073.
16.Sobanski, E. Psychiatric comorbidity in adults with attention-deficit/ hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 256 (Suppl 1), i26–i31 (2006). https://doi.org/10.1007/s00406-006-1004-4
17.Young S, Asherson P, Lloyd T, Absoud M, Arif M, Colley WA, Cortese S, Cubbin S, Doyle N, Morua SD, Ferreira-Lay P, Gudjonsson G, Ivens V, Jarvis C, Lewis A, Mason P, Newlove-Delgado T, Pitts M, Read H, van Rensburg K, Zoritch B, Skirrow C. Failure of Healthcare Provision for Attention-Deficit/Hyperactivity Disorder in the United Kingdom: A Consensus Statement. Front Psychiatry. 2021 Mar 19;12:649399. doi: 10.3389/fpsyt.2021.649399. PMID: 33815178; PMCID: PMC8017218.
18.Franke B, Michelini G, Asherson P, Banaschewski T, Bilbow A, Buitelaar JK, Cormand B, Faraone SV, Ginsberg Y, Haavik J, Kuntsi J, Larsson H, Lesch KP, Ramos-Quiroga JA, Réthelyi JM, Ribases M, Reif A. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. Eur Neuropsychopharmacol. 2018 Oct;28(10):1059-1088. doi: 10.1016/j.euroneuro.2018.08.001. Epub 2018 Sep 6. PMID: 30195575; PMCID: PMC6379245.
19.Brunkhorst-Kanaan N, Libutzki B, Reif A, Larsson H, McNeill RV, Kittel- Schneider S. ADHD and accidents over the life span - A systematic review. Neurosci Biobehav Rev. 2021 Jun;125:582-591. doi: 10.1016/j. neubiorev.2021.02.002. Epub 2021 Feb 11. PMID: 33582234.
20.Young S, Adamo N, Ásgeirsdóttir BB, Branney P, Beckett M, Colley W, Cubbin S, Deeley Q, Farrag E, Gudjonsson G, Hill P, Hollingdale J, Kilic O, Lloyd T, Mason P, Paliokosta E, Perecherla S, Sedgwick J, Skirrow C, Tierney K, van Rensburg K, Woodhouse E. Females with ADHD:
An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and women. BMC Psychiatry. 2020 Aug 12;20(1):404. doi: 10.1186/s12888-020-02707-9. PMID: 32787804; PMCID: PMC7422602.
21.A Call to Action The Majority of Women with ADHD are Being Left Behind by the Health System: ADHD Foundation 2021
22.Dorani F, Bijlenga D, Beekman ATF, van Someren EJW, Kooij JJS. Prevalence of hormone-related mood disorder symptoms in women with ADHD. J Psychiatr Res. 2021 Jan;133:10-15. doi: 10.1016/j. jpsychires.2020.12.005. Epub 2020 Dec 3. PMID: 33302160.
23.Wilens TE, Morrison NR, Prince J. An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother. 2011 Oct;11(10):1443-65. doi: 10.1586/ern.11.137. PMID: 21955201; PMCID: PMC3229037.
24.https://www.google.com/search?client=firefox-b-d&q=adhd+consultanc y/#lrd=0x487601c8ea6bbb33:0x9027f86cc5820864,1
Dr Helen Read MBChB MRCPsych
ADHD Consultancy Ltd,
25 Warminster Road, London SE25 4AS
E: doctor@adhdconsultancy.co.uk Twitter: @DoctorHelenRead
 28


































































   26   27   28   29   30